Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years: Results from 2 randomized controlled trials

Immunogenicity and safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine were evaluated in healthy Chinese females aged 9–45 years in 2 phase IIIB, randomized, controlled trials. Girls aged 9–17 years (ClinicalTrials.gov, NCT00996125) received vaccine (n = 374) or control (n = 376)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhu, Fengcai, Li, Juan, Hu, Yuemei, Zhang, Xiang, Yang, Xiaoping, Zhao, Hui, Wang, Junzhi, Yang, Jianguo, Xia, Guodong, Dai, Qinyong, Tang, Haiwen, V Suryakiran, Pemmaraju, Datta, Sanjoy K, Descamps, Dominique, Bi, Dan, Struyf, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4186032/
https://ncbi.nlm.nih.gov/pubmed/25424785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28702
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados